- Home
- PASG vs NMTC Comparison
PASG vs NMTC Comparison
Compare PASG & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PASG | NMTC |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 31.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PASG | NMTC |
|---|---|---|
| Price | $9.95 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $34.50 | $2.23 |
| AVG Volume (30 Days) | 46.5K | ★ 198.6K |
| Earning Date | 11-10-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,629,051.00 |
| Revenue This Year | N/A | $162.84 |
| Revenue Next Year | N/A | $26.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 69.00 |
| 52 Week Low | $5.12 | $0.40 |
| 52 Week High | $20.20 | $1.39 |
Technical Indicators
Market Signals| Indicator | PASG | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 46.82 |
| Support Level | $9.72 | $0.55 |
| Resistance Level | $10.71 | $0.75 |
| Average True Range (ATR) | 0.84 | 0.05 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 73.25 | 56.46 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.